Results for review: 696

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen down 7 pct; Elan shares off 17 pct (Add FDA confirming 23...

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen down 5.8 pct; Elan shares off 20.5 pct (Add FDA statement, updates...

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen down 5.5 pct; Elan shares fall 20 pct (Updates share prices) BOSTON,...

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen fall 5.8 pct; Elan shares plunge 19 pct (Adds company comment, background)...

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen fall 5.6 pct; Elan shares plunge 21 pct (Updates with analyst comment,...

* European regulators to review risk, benefit of Tysabri * Review follows reports of 23 cases of PML worldwide * Shares of Biogen plunge 6.1 pct; Elan shares fall 21 pct (Updates with details, analyst...

BOSTON, Oct. 23 - European regulators said they have begun a review of the multiple sclerosis drug Tysabri in light of 23 reports of a potentially deadly brain infection known as progressive multifocal leukoencephalopathy, or...

* India to review fuel prices in 15-20 days - Oil Minister * Analysts say a hike may raise inflation pressures * Crude oil prices up $10 a barrel this month MUMBAI, Oct 20 -...

* CEO Lewis to receive no pay, bonus for 2009 work * Shift comes from demands by pay czar * Lewis' retirement pay still under review * Lewis got nearly $10 million in 2008 CHARLOTTE/WASHINGTON,...

ROMANIA PRESIDENT: IMF POSTPONED REVIEW MISSION TO ROMANIA UNTIL NEW GOVERNMENT INSTALLED...